Abstract
True refractory hypertension is relatively rare, but the causes of pseudoresistance are many. Thus, all patients should be considered medically treatable until proved otherwise. Initial workup should seek to determine whether the patient, the physician, or the hypertension is resistant. And one must make sure that therapy is indeed tailored to the patient's individual pathophysiology.

This publication has 1 reference indexed in Scilit: